Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pfizer (Ireland) Revenue	12.70M	18.23M	12.62M
Pfizer (Ireland) Revenue Growth	-30.32%	44.46%	0.76%
Fiocruz (Brazil) Revenue	-	11.06M	11.03M
Fiocruz (Brazil) Revenue Growth	-	0.28%	6.06%
Chiesi (Italy) Revenue	26.03M	22.51M	29.33M
Chiesi (Italy) Revenue Growth	15.60%	-23.25%	67.66%
Total Revenue from Selling Goods	49.23M	51.80M	52.98M
Total Revenue from Selling Goods Growth	-4.97%	-2.23%	31.08%
Revenue from License and R&D Services	27.16M	942.00K	418.00K
Revenue from License and R&D Services Growth	2782.70%	125.36%	-98.33%
Revenue (Total)	76.38M	52.74M	53.40M
Revenue (Total) Growth	44.81%	-1.23%	-18.47%